370 related articles for article (PubMed ID: 9486396)
1. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
2. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Prednisolone Treatment on Cytokine Expression in Patients with Erythema Nodosum Leprosum Reactions.
Negera E; Walker SL; Bobosha K; Bekele Y; Endale B; Tarekegn A; Abebe M; Aseffa A; Dockrell HM; Lockwood DN
Front Immunol; 2018; 9():189. PubMed ID: 29479352
[TBL] [Abstract][Full Text] [Related]
4. Sequential erythema nodosum leprosum and reversal reaction with similar lesional cytokine mRNA patterns in a borderline leprosy patient.
Moraes MO; Sampaio EP; Nery JA; Saraiva BC; Alvarenga FB; Sarno EN
Br J Dermatol; 2001 Jan; 144(1):175-81. PubMed ID: 11167702
[TBL] [Abstract][Full Text] [Related]
5. The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy.
Nery JA; Perissé AR; Sales AM; Vieira LM; Souza RV; Sampaio EP; Sarno EN
Indian J Lepr; 2000; 72(4):457-67. PubMed ID: 11212480
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory drugs block cytokine mRNA accumulation in the skin and improve the clinical condition of reactional leprosy patients.
Moraes MO; Sarno EN; Teles RM; Almeida AS; Saraiva BC; Nery JA; Sampaio EP
J Invest Dermatol; 2000 Dec; 115(6):935-41. PubMed ID: 11121122
[TBL] [Abstract][Full Text] [Related]
7. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
Sampaio EP; Kaplan G; Miranda A; Nery JA; Miguel CP; Viana SM; Sarno EN
J Infect Dis; 1993 Aug; 168(2):408-14. PubMed ID: 8335978
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor production in patients with leprosy.
Barnes PF; Chatterjee D; Brennan PJ; Rea TH; Modlin RL
Infect Immun; 1992 Apr; 60(4):1441-6. PubMed ID: 1548069
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline in the treatment of erythema nodosum leprosum.
De Carsalade GY; Achirafi A; Flageul B
J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
[TBL] [Abstract][Full Text] [Related]
10. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
[TBL] [Abstract][Full Text] [Related]
11. Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2R.
Vieira LM; Sampaio EP; Nery JA; Duppre NC; Albuquerque EC; Scheinberg MA; Sarno EN
Rev Inst Med Trop Sao Paulo; 1996; 38(2):103-11. PubMed ID: 9071029
[TBL] [Abstract][Full Text] [Related]
12. Is pentoxifylline a viable alternative in the treatment of ENL?
Sarno EN; Nery JA; Garcia CC; Sampaio EP
Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):570-1. PubMed ID: 8642222
[No Abstract] [Full Text] [Related]
13. Cytokine mRNA expression in leprosy: a possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL).
Moraes MO; Sarno EN; Almeida AS; Saraiva BC; Nery JA; Martins RC; Sampaio EP
Scand J Immunol; 1999 Nov; 50(5):541-9. PubMed ID: 10564558
[TBL] [Abstract][Full Text] [Related]
14. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states.
Sarno EN; Grau GE; Vieira LM; Nery JA
Clin Exp Immunol; 1991 Apr; 84(1):103-8. PubMed ID: 2015700
[TBL] [Abstract][Full Text] [Related]
17. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum.
Santos DO; Suffys PN; Bonifácio K; Marques MA; Sarno EN
Clin Immunol Immunopathol; 1993 Jun; 67(3 Pt 1):199-203. PubMed ID: 8500267
[TBL] [Abstract][Full Text] [Related]
18. Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum.
Foss NT; de Oliveira EB; Silva CL
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):218-26. PubMed ID: 8371031
[TBL] [Abstract][Full Text] [Related]
19. Does pentoxifylline find a place in the armementarium of leprologists in type II reaction?
Chatterjee M; Jaiswal AK
Indian J Lepr; 2002; 74(4):329-34. PubMed ID: 12624981
[TBL] [Abstract][Full Text] [Related]
20. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction.
Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V
Front Immunol; 2024; 15():1366125. PubMed ID: 38715615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
